167
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

, , , , , , , & show all
Pages 905-914 | Published online: 24 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Xiaoyu Liu, Yarong Wu, Ying Zhu, Peiyao Jia, Xue Li, Xinmiao Jia, Wei Yu, Yujun Cui, Ruifu Yang, Wei Xia, Yingchun Xu & Qiwen Yang. (2022) Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China. Emerging Microbes & Infections 11:1, pages 648-661.
Read now
Jide Sun, Li Du, Li Yan, Wei Dai, Zhu Wang & Xiuyu Xu. (2020) Eight-Year Surveillance of Uropathogenic Escherichia coli in Southwest China. Infection and Drug Resistance 13, pages 1197-1202.
Read now
Abdullah Tarık Aslan & Murat Akova. (2019) Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options. Expert Review of Anti-infective Therapy 17:12, pages 969-981.
Read now

Articles from other publishers (14)

Yihong Sun, Jia Fan, Gang Chen, Xiaofei Chen, Xiaoling Du, Ye Wang, Hui Wang, Fang Sun, Matthew G. Johnson, Mekki Bensaci, Jennifer A. Huntington & Christopher J. Bruno. (2022) A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections. International Journal of Infectious Diseases 123, pages 157-165.
Crossref
Katsumi Shigemura & Kiyohito Ishikawa. (2022) AAUS guideline for acute uncomplicated pyelonephritis. Journal of Infection and Chemotherapy 28:8, pages 1092-1097.
Crossref
Mianzhi Yao, Qianhui Zhu, Jin Zou, Abebe Mekuria Shenkutie, Songnian Hu, Jiuxin Qu, Zilong He & Polly H. M. Leung. (2022) Genomic Characterization of a Uropathogenic Escherichia coli ST405 Isolate Harboring blaCTX-M-15-Encoding IncFIA-FIB Plasmid, blaCTX-M-24-Encoding IncI1 Plasmid, and Phage-Like Plasmid. Frontiers in Microbiology 13.
Crossref
Shao-Huan LanChien-Ming ChaoShen-Peng ChangLi-Chin LuChih-Cheng Lai. (2021) Clinical Efficacy and Safety of Cefoperazone–Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis. Surgical Infections 22:8, pages 763-770.
Crossref
Qian Zeng, Shuzhen Xiao, Feifei Gu, Weiping He, Qing Xie, Fangyou Yu & Lizhong Han. (2021) Antimicrobial Resistance and Molecular Epidemiology of Uropathogenic Escherichia coli Isolated From Female Patients in Shanghai, China. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Jingjing Quan, Honglei Dai, Weichao Liao, Dongdong Zhao, Qiucheng Shi, Linghong Zhang, Keren Shi, Murat Akova & Yunsong Yu. (2021) Etiology and prevalence of ESBLs in adult community-onset urinary tract infections in East China: A prospective multicenter study. Journal of Infection 83:2, pages 175-181.
Crossref
Peiyao Jia, Ying Zhu, Xue Li, Timothy Kudinha, Yang Yang, Ge Zhang, Jingjia Zhang, Yingchun Xu & Qiwen Yang. (2021) High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study. Frontiers in Microbiology 12.
Crossref
Eva RaphaelHenry F. Chambers. (2021) Differential Trends in Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections in Four Health Care Facilities in a Single Metropolitan Area: A Retrospective Analysis . Microbial Drug Resistance 27:2, pages 154-161.
Crossref
Qiwen Yang, Hui Zhang, Yunsong Yu, Haishen Kong, Qiong Duan, Yong Wang, Shufang Zhang, Ziyong Sun, Kang Liao, Li Gu, Xiaofeng Jiang, Anhua Wu, Wenxiang Huang, Bin Shan, Mei Kang, Fupin Hu, Hua Yu, Weijuan Zhang & Yingchun Xu. (2020) In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015–2018. Clinical Infectious Diseases 71:Supplement_4, pages S427-S435.
Crossref
Gonca YÜKSEK, Nagihan MEMİŞ & Şükrü ÖKSÜZ. (2020) İdrar Örneklerinden İzole Edilen Escherichia coli Kökenlerinin Antibiyotik Duyarlılığı. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.
Crossref
Camilo Hernández-Avilés, Charles C. Love, Rosanna Serafini, Luisa Ramírez-Agámez, Dale E. Kelley, Elena Martínez de Andino, Sheila R. Teague, Katrina A. LaCaze, Steven P. Brinsko & Dickson D. Varner. (2020) Inclusion of supplemental antibiotics (amikacin – penicillin) in a commercial extender for stallion semen: Effects on sperm quality, bacterial growth, and fertility following cooled storage. Theriogenology 158, pages 209-217.
Crossref
Xiaojuan Wang, Chunjiang Zhao, Qi Wang, Zhanwei Wang, Xinyue Liang, Feifei Zhang, Yawei Zhang, Han Meng, Hongbin Chen, Shuguang Li, Chengcheng Zhou, Henan Li & Hui Wang. (2020) In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China. Journal of Antimicrobial Chemotherapy 75:7, pages 1850-1858.
Crossref
Li-Chin Lu, Chih-Cheng Lai, Shen-Peng Chang, Shao-Huan Lan, Shun-Hsing Hung & Wei-Ting Lin. (2020) Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections. Medicine 99:19, pages e19960.
Crossref
Yang-mei Xiong & Xin Rao. (2020) Clinical and Microbiological Characteristics of Patients with Complicated Intra-abdominal Infections in Intensive Care Unit. Current Medical Science 40:1, pages 104-109.
Crossref